insights_auto
Why is ICLR down 2.92%?
Dive Deeperchevron_right
ICLR:NASDAQ
ICON PLC
$194.65
arrow_downward
-2.92%(-5.86) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICLR...
Open
$200.56
High
$200.56
Low
$194.39
Mkt. cap
14.58B
Avg. vol.
1.11M
Volume
966.54K
P/E ratio
79.55
52-wk high
$219.04
52-wk low
$66.57
EPS
$2.45
Beta
1.19
Shares outstanding
74.92M
No. of employees
40K
Open
$200.56
High
$200.56
Low
$194.39
Mkt. cap
14.58B
Avg. vol.
1.11M
Volume
966.54K
P/E ratio
79.55
52-wk high
$219.04
52-wk low
$66.57
EPS
$2.45
Beta
1.19
Shares outstanding
74.92M
No. of employees
40K
News stories
From web sources and news partners
24/7 Wall St.
·
1 hour ago
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Nasdaq
·
1 day ago
Chartstopper: November 13, 2026
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.
As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC